Arvinas ARVN
NASDAQ ARVN
$9.39 +0.08 (+0.86%)
As of: Sep 4, 2026 · 3:59 PM EDT

Arvinas (ARVN) FCF Margin (2017 - 2026)

Arvinas (ARVN) posted quarterly FCF Margin of 451.92% for Q1 2026, down 40462.0% year-over-year from N/an in Q1 2025, and down 48.04% quarter-over-quarter from 305.26% in Q4 2025.

Analysis

Arvinas (ARVN) FCF Margin (2017 - 2026) Analysis & Trends

Arvinas' FCF Margin history runs 10 years deep, the most recent figure standing at 451.92% for Q1 2026.

  • In Q1 2026, FCF Margin fell 40462.0% year-over-year to 451.92%; the TTM figure through Mar 2026 stood at 285.57% (down 22633.0% YoY), while the FY2025 annual figure was 104.38%, down 525.0% from the prior year.
  • FCF Margin for Q1 2026 stood at 451.92%, down from 305.26% in the prior quarter.
  • The five-year high for FCF Margin was 193.04% in Q4 2023, with the low at 451.92% in Q1 2026.
  • The 5-year median for FCF Margin is 200.0% (2022), against an average of 194.59%.
  • Peak annual rise in FCF Margin reached 64310 bps in 2022, while the deepest fall reached 754301 bps in 2022.
  • Arvinas' FCF Margin stood at 187.83% in 2022, then soared by 203 bps to 193.04% in 2023, then slumped by 174 bps to 142.57% in 2024, then slumped by 114 bps to 305.26% in 2025, then sank by 48 bps to 451.92% in 2026.
  • Business Quant data shows ARVN's FCF Margin at 451.92% in Q1 2026, 305.26% in Q4 2025, and 141.29% in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 30.39%
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 13.35%
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -388.28%
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 25.68%
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 22.62%
8 Royalty Pharma 28.45 Bn 27.61 Bn - 70.82%
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -22.35%
10 Arvinas 609.77 Mn 41.87 Mn - -19.42%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -19.42%
Mar 31, 2026 -451.92%
Dec 31, 2025 -322.11%
Sep 30, 2025 -141.29%
Jun 30, 2025 -431.25%
Mar 31, 2025 -47.30%
Dec 31, 2024 -142.57%
Sep 30, 2024 -125.68%
Jun 30, 2024 64.84%
Mar 31, 2024 -385.77%
Dec 31, 2023 193.04%
Sep 30, 2023 -248.27%
Jun 30, 2023 -163.85%
Mar 31, 2023 -284.00%
Dec 31, 2022 -191.27%
Sep 30, 2022 -207.23%
Jun 30, 2022 -236.69%
Mar 31, 2022 -223.40%
Dec 31, 2021 -113.25%
Sep 30, 2021 7,313.98%